|
[1]
|
R. Grainger Bisset, “Max Wichtl Herbal Drugs and Phytopharmaceuticals a Handbook for Practice on a Scientific Basis,” CRC Press, Boca Raton, 2000.
|
|
[2]
|
M. Moran, M. McAlexander, T Biro and A Szallasi, “Transient Receptor Potential Channels as Therapeutic Targets,” Nature Reviews, Vol. 10, 2011, pp. 601-620.
doi:10.1038/nrd3456
|
|
[3]
|
H. Xu, N. Blair and D. Clapham, “Camphor Activates and Strongly Desensitizes the Transient Receptor Potential Vanilloid Subtype 1 Channel in Vanilloid-Independent Mechanism,” Journal of Neuroscience, Vol. 25, No. 39, 2005, pp. 8924-8937.
doi:10.1523/JNEUROSCI.2574-05.2005
|
|
[4]
|
A. Martinez, M. Gonzalez-Trujano, E. Aguirre-Hernandez, J. Moreno, M. Soto-Hernandez and F. Lopez-Munoz, “Antinociceptive Activity of Tilia americana var. mexicana Inflorescences and Quercetin in the Formalin Test and in an Arthritic Pain Model in Rats,” Neuropharmacology, Vol. 56, No. 2, 2009, pp. 564-571.
doi:10.1016/j.neuropharm.2008.10.010
|
|
[5]
|
A. Martinez, M. Gonzalez-Trujano, F. Pellicer, F. Lo-pez-Munoz and A. Navarette, “Antinociceptive Effect and GC/MS Analysis of Rosmarinus officinalis L. Essential Oil from Its Aerial Parts,” Planta Medica, Vol. 75, No. 5, 2009, pp. 508-511. doi:10.1055/s-0029-1185319
|
|
[6]
|
C. Liapi, G. Anifandis, I. Chinou, A. Kourounakis, S. Theodosopoulos and P. Galanopoulou, “Antinociceptive Properties of 1,8-Cineole and Beta-Pinene, from the Essential Oil of Eucalyptus camaldulensis Leaves, in Rodents,” Planta Medica, Vol. 73, No. 12, 2007, pp. 1247-1254. doi:10.1055/s-2007-990224
|
|
[7]
|
R. Granger, E. Campbell and G. Johnston, “(+)- and (?)-Borneol: Efficacious Positive Modulators of GABA Action at Human Recombinant α1β2γ2L GABAA Receptors,” Biochemical Pharmacology, Vol. 69, No. 7, 2005, pp. 1101-1111. doi:10.1016/j.bcp.2005.01.002
|
|
[8]
|
K. Hold, N. Sirisoma, T. Ikeda, T. Narahashi and J. Casida, “Alpha-Thujone (the Active Component of Absinthe): Gamma-Aminobutyric Acid Type A Receptor Modulation and Metabolic Detoxification,” Proceedings of the National Academy of Science USA, Vol. 97, No. 8, 2000, pp. 4417-4418. doi:10.1073/pnas.070042397
|
|
[9]
|
J. Vriens, G. Appendino and B. Nilius, “Pharmacology of Vanilloid Transient Receptor Potential Cation Channels,” Molecular Pharmacology, Vol. 75, No. 6, 2009, pp. 1262-1279. doi:10.1124/mol.109.055624
|
|
[10]
|
A. Vogt-Eisele, K. Weber, M. Sherkheli, G. Vielhaber, J. Panten, G. Gisselmann and H. Hatt, “Monoterpenoid Agonists of TRPV3,” British Journal of Pharmacology, Vol. 151, No. 4, 2007, pp. 530-540.
doi:10.1038/sj.bjp.0707245
|
|
[11]
|
A. Basbaum, D. Bautista, G. Scherrer and D. Julius,” Cellular and Molecular Mechanisms of Pain,” Cell, Vol. 139, No. 2, 2009, pp. 267-284.
doi:10.1016/j.cell.2009.09.028
|
|
[12]
|
T. Ishida, “Biotransformation of Terpenoids by Mammals, Microorganisms, and Plant-Cultured Cells,” Chemical Biodiversity, Vol. 2, No. 5, 2005, pp. 569-590.
doi:10.1002/cbdv.200590038
|
|
[13]
|
C. Lin, C. Chen, T. Lin, J. Tung and S. Wang, “Anti-Inflammation Activity of Fruit Essential Oil from Cinnamomum insularimontanum Hayata,” Bioresource Technology, Vol. 99, No. 18, 2008, pp. 8783-8787.
doi:10.1016/j.biortech.2008.04.041
|
|
[14]
|
Y. Tung, M. Chua, S. Wang and S. Chang, “Anti-Inflammation Activities of Essential Oil and Its Constituents from Indigenous Cinnamon (Cinnamomum osmophloeum) Twigs,” Bioresource Technology, Vol. 99, No. 9, 2008, pp. 3908-3913. doi:10.1016/j.biortech.2007.07.050
|
|
[15]
|
A. Ruikar, A. Misar, R. Jadhav, S. Rojatkar, A. Mujumdar, V. Puranik and N. Deshpande, “Sesquiterpene Lactone, a Potent Drug Molecule from Artemisia Pallens Wall with Anti-Inflammatory Activity,” Arzneimittel Forschung, Vol. 61, No. 9, 2011, pp. 510-514.
doi:10.1055/s-0031-1296236
|
|
[16]
|
L. Fonseca, S. Dadarkar, A. Lobo, P. Mishra, A. Thakkar, S. Chandrababu and M. Padigaru, “NF-kappaB Mediated Anti-Inflammatory Activity of the Sesquiterpene Lactone 7-Hydroxyfrullanolide,” European Journal of Pharmacology, Vol. 657, No. 1-3, 2011, pp. 41-50.
doi:10.1016/j.ejphar.2011.01.050
|
|
[17]
|
Y. Li, Y. Xian, S. Ip, Z. Su, J. Su, J. He, Q. Xie, X. Lai and Z. Lin, “Anti-Inflammatory Activity of Patchouli Alcohol Isolated from Pogostemonis Herba in Animal Models,” Fitoterapia, Vol. 82, No. 8, 2011, pp. 1295- 1301. doi:10.1016/j.fitote.2011.09.003
|
|
[18]
|
C. Rummel, R. Gerstberger, J. Roth and T. Hubschle, “Parthenolide Attenuates LPS-Induced Fever, Circulating Cytokines and Markers of Brain Inflammation in Rats,” Cytokine, Vol. 56, No. 3, 2011, pp. 739-748.
doi:10.1016/j.cyto.2011.09.022
|
|
[19]
|
S. Kim, E. Jung, J. Kim, Y. Park, J. Lee and D. Park, “Inhibitory Effects of (?)-Alpha-Bisabolol on LPS Induced Inflammatory Response in RAW264.7 Macrophages,” Food and Chemical Toxicology, Vol. 49, No. 10, 2011, pp. 2580-2585. doi:10.1016/j.fct.2011.06.076
|
|
[20]
|
A. Hensel, M. Maas, J. Sendker, M. Lechtenberg, F. Petereit, A. Deters, T. Schmidt and T. Stark, “Eupatorium perfoliatum L.: Phytochemistry, Traditional Use and Current Applications,” Journal of Ethnopharmacology, Vol. 138, No. 3, 2011, pp. 641-651.
doi:10.1016/j.jep.2011.10.002
|
|
[21]
|
X. Cheng, Q. Zeng, J. Ren, J. Qin, S. Zhang, Y. Shen, J. Zhu, F. Zhang, R. Chang, Y. Zhu, W. Zhang and H. Jin, “Sesquiterpene lactones from Inula falconeri, a Plant Endemic to the Himalayas, as Potential Anti-Inflammatory Agents,” European Journal of Medicinal Chemistry, Vol. 46, No. 11, 2011, pp. 5408-5415.
doi:10.1016/j.ejmech.2011.08.047
|
|
[22]
|
R. Landberg, Q. Sun, E. Rimm, A. Cassidy, A. Scalbert, C. Mantzoros, F. Hu and R. van Dam, “Selected Dietary Flavonoids Are Associated with Markers of Inflammation and Endothelial Dysfunction in Women,” Journal of Nutrition, Vol. 141, No. 4, 2011, pp. 618-625.
doi:10.3945/jn.110.133843
|
|
[23]
|
G. Autore, L. Rastrelli, M. Lauro, S. Marzocco, R. Sorrenetino, U. Sorrentino, A. Pinto and R. Aquino, “Inhibition of Nitric Oxide Synthase Expression by a Methanolic Extract of Crescentia alata and Its Derived Flavonols,” Life Science, Vol. 70, No. 5, 2001, pp. 523-534.
doi:10.1016/S0024-3205(01)01425-4
|
|
[24]
|
W. Kwak, T. Moon, C. Lin, H. Rhyn, H. Jung, E. Lee, D. Kwon, K. Son, H. Kim, S. Kang, M. Murakami, I. Kudo and H. Chang, “Papyriflavolol A from Broussonetia papyrfera Inhibits the Passive Cutaneous Anaphylaxis Reaction and Has a Secretory Phospholipase A2 Inhibitory Activity,” Biological and Pharmaceutical Bulletin, Vol. 26, 2003, pp. 299-302. doi:10.1248/bpb.26.299
|
|
[25]
|
P. Remberg, L. Bjork, T. Hedner and O. Sterner, “Characteristics, Clinical Effect Profile and Tolerability of a Nasal Spray Preparation of Artemisia abrotanum L. for Allergic Rhinitis,” Phytomedicine, Vol. 11, No. 1, 2004, pp. 36-42. doi:10.1078/0944-7113-00350
|
|
[26]
|
T. Barros, L. de Freitas, H. Filho, X. Nunes, A. Giulietti, G. de Souza, R. dos Santos, M. Soares and C. Villarreal, “Antinociceptive and Anti-Inflammatory Properties of 7-Hydroxycoumarin in Experimental Animal Models: Potential Therapeutic for the Control of Inflammatory Chronic Pain,” Journal of Pharmacy and Pharmacology, Vol. 62, No. 2, 2010, pp. 205-213.
doi:10.1211/jpp.62.02.0008
|
|
[27]
|
M. Kurokawa, W. Watanabe, T. Shimizu, R. Sawamura and K. Shiraki, “Modulation of Cytokine Production by 7-Hydroxycoumarin in Vitro and Its Efficacy against Influenza Infection in Mice,” Antiviral Research, Vol. 85, No. 2, 2010, pp. 373-380.
doi:10.1016/j.antiviral.2009.11.001
|
|
[28]
|
B. Ramesh and K. Pugalendi, “Antihyperglycemic Effect of Umbelliferone in Streptozotocin Diabetic Rats,” Journal of Medicinal Food, Vol. 9, No. 4, 2006, pp. 562-566. doi:10.1089/jmf.2006.9.562
|
|
[29]
|
B. Ramesh and K. Pugalendi, “Antihyperlipidemic and Antidiabetic Effects of Umbelliferone in Streptozotocin Diabetic Rats,” Yale Journal of Biology and Medicine, Vol. 78, No. 4, 2005, pp. 189-196.
|
|
[30]
|
S. Pan, Y. Huang, J. Guh, C. Peng and C. Teng, “Esculetin Inhibits Ras Mediated Cell Proliferation and Attenuates Vascular Restenosis Following Angioplasty in Rats,” Biochemical Pharmacology, Vol. 65, No. 11, 2003, pp. 1897-1905. doi:10.1016/S0006-2952(03)00161-8
|
|
[31]
|
K. Matsunaga, N. Yoshimi, Y. Yamada, M. Shimizu, K. Kawabata, Y. Ozawa, A. Hara and H. Mori, “Inhibitory Effects of Nambumetone, a Cyclooxygenase 2 Inhibitor, and Esculetin, a Lipoxygenase Inhibitor, on N-Methyl-N-Nitorosourea Induced Mammary Carcinogenesis in Rats,” Japanese Journal of Cancer Research, Vol. 89, No. 5, 1998, pp. 496-501.
doi:10.1111/j.1349-7006.1998.tb03289.x
|
|
[32]
|
M. Marshall, J. Mohler, K. Edmonds, B. Williams, K. Butler, M. Ryles, L. Weiss, D. Urban, A. Bueschen and M. Markiewicz, “An Updated Review of the Clinical Development of Coumarin (1,2-Benzopyrone) and 7-Hydroxycoumarin,” Journal of Cancer Research and Clinical Oncology, Vol. 120, No. Supplement 1, 1994, pp. S39-S42. doi:10.1007/BF01377124
|
|
[33]
|
L. Kapoor, “CRC Handbook of Ayurvedic Medicinal Plants,” CRC Press, Boca Raton, 1990.
|
|
[34]
|
J. D. Adams, C. Garcia and E. J. Lien, “A Comparison of Chinese and American Indian (Chumash) Medicine,” Evidence-Based Complementary and Alternative Medicine, Vol. 7, No. 2, 2008, pp. 219-225.
|
|
[35]
|
W. Tang and G. Eisenbrand, “Handbook of Chinese Medicinal Plants,” Vol. 1, Wiley VCH, Weinheim, 2011.
|
|
[36]
|
C. Garcia and J. D. Adams, “Healing with Medicinal Plants of the West—Cultural and Scientific Basis for Their Use,” 2nd Edition, Abedus Press, La Crescenta, 2009.
|
|
[37]
|
J. D. Adams and C. Garcia, “Women’s Health among the Chumash,” Evidence Based Comparative and Alternative Medicine, Vol. 3, No. 1, 2006, pp. 125-131.
doi:10.1093/ecam/nek021
|
|
[38]
|
J. Amiel, S. Mathew, A. Garakani, A. Neumeister and D. Charney, “Neurobiology of Anxiety Disorders,” In: A. Schatzberg and C. Nemeroff, Eds., Textbook of Psychopharmacology, The American Psychiatric Publishing Co, Washington DC, 2009, pp. 965-985.
|
|
[39]
|
A. Penissi, L. Mariani, M. Souto, J. Guzman and R. Piezzie, “Changes in Gastroduodenal 5-Hydroxytryptamine Containing Cells Induced by Dehydroleucodine,” Cells Tissues Organs, Vol. 166, No. 3, 2000, pp. 259-266.
doi:10.1159/000016739
|
|
[40]
|
A. Penissi, M. Rudolph, M. Villar, R. Coll, T. Fogal and R. Piezzi, “Effect of Dehydroleucodine on Histamine and Serotonin Release from Mast Cells in the Isolate Mouse Jejunum,” Inflammation Research, Vol. 52, No. 5, 2003, pp. 199-205.
|
|
[41]
|
A. Penissi, M. Vera, M. Mariani, M. Rudolph, J. Cenal, J. de Rosas, T. Fogal, C. Tonn, L. Favier, O. Giordano and R. Piezzi, “Novel Anti-Ulcer α,β-Unsaturated Lactones Inhibit Compound 48/80 Induced Mast Cell Degranulation,” European Journal of Pharmacology, Vol. 612, No. 1-3, 2009, pp. 122-130. doi:10.1016/j.ejphar.2009.03.052
|
|
[42]
|
G. Rodriguez, L. Pestchanker, M. Pestchanker, O. Giordano, “Guaianolides and Other Constituents from Artemisia douglasiana,” Phytochemistry, Vol. 29, No. 9, 1990, pp. 3028-3029. doi:10.1016/0031-9422(90)87129-I
|
|
[43]
|
L. Jakupovic, V. Chau-Thi, U. Warning, F. Bohlmann and H. Greger, “11b,13-Dihdroguaianolides from Artemisia douglasiana and a Thiophene Acetylene from A. Schmidtiana,” Phytochemistry, Vol. 25, 1986, pp. 1663-1667.
|
|
[44]
|
S. Matsueda and T. Geissman, “Sesquiterpene Lactones of Artemisia Species. IV. Douglanine from Artemisia douglasiana Bess,” Tetrahedron Letters, Vol. 8, No. 23, 1967, pp. 2159-2162.
doi:10.1016/S0040-4039(00)90788-3
|
|
[45]
|
S. Matsueda and T. Geissman, “Sesquiterpene Lactones of Artemisia Species. III. Arglanine from Artemisia douglasiana Bess,” Tetrahedron Letters, Vol. 8, No. 21, 1967, pp. 2013-2015. doi:10.1016/S0040-4039(00)90776-7
|
|
[46]
|
F. Bohlmann, N. Ates, J. Jakupovic, R. King and H. Robinson, “Types of Sequiterpenes from Artemisia douglasiana,” Phytochemistry, Vol. 21, No. 11, 1982, pp. 2691-2697. doi:10.1016/0031-9422(82)83100-2
|
|
[47]
|
K. Lee, S. Matsueda and T. Geissman, “Sesquiterpene Lactones of Artemisia: New Guaianolides from Fall Growth of A. douglasiana,” Phytochemistry, Vol. 10, No. 2, 1971, pp. 405-410. doi:10.1016/S0031-9422(00)94057-3
|
|
[48]
|
K. Meepagala, J. Kuhajek, G. Sturtz and D. Wedge, “Vulgarone B, the Antifungal Constituent in the Steam Distilled Fraction of Artemisia douglasiana,” Journal of Chemical Ecology, Vol. 29, No. 8, 2003, pp. 1771-1780.
doi:10.1023/A:1024842009802
|
|
[49]
|
T. Guardia, A. Juarez, E. Guerreiro, J. Guzman and L. Pelzer, “Anti-Inflammatory Activity and Effect on Gastric Acid Secretion of Dehydroleucodine Isolated from Artemisia douglasiana,” Journal of Ethnopharmacology, Vol. 88, No. 2-3, 2003, pp. 195-198.
doi:10.1016/S0378-8741(03)00211-3
|
|
[50]
|
G. Wendel, A. Maria, J. Guzman, O. Giordano and L. Pelzer, “Antidiarrheal Activity of Dehydroleucodine Isolated from Artemisia douglasiana,” Fitoterapia, Vol. 79, No. 1, 2008, pp. 1-5. doi:10.1016/j.fitote.2007.05.006
|
|
[51]
|
A. Mahmoud and A. Ahmed, “Alpha-Pinene Type Monoterpenes and Other Constituents from Artemisia suksdorfii,” Phytochemistry, Vol. 67, No. 19, 2006, pp. 2103- 2109. doi:10.1016/j.phytochem.2006.06.013
|
|
[52]
|
T. Ohno, A. Nagatsu, M. Nagawa, M. Inoue, Y. Li, S. Minatoguchi, H. Mizukami and H. Fujiwara, “New Sesquiterpene Lactones from Water Extract of the Root of Lindera strychnifolia with Cytotoxicity against Human Small Cell Lung Cancer Cell, SBC-3,” Tetrahedron Letters, Vol. 46, No. 50, 2005, pp. 8657-8660.
doi:10.1016/j.tetlet.2005.10.051
|
|
[53]
|
H. Xu, N. Blair and D. Clapham, “Camphor Activates and Strongly Desensitizes the Transient Receptor Potential Vanilloid Subtype 1 Channel in Vanilloid-Independent Mechanism,” Journal of Neuroscience, Vol. 25, No. 39, 2005, pp. 8924-8937.
doi:10.1523/JNEUROSCI.2574-05.2005
|
|
[54]
|
A. Martinez, M. Gonzalez-Trujano, F. Pellicer, F. Lopez-Munoz and A. Navarette, “Antinociceptive Effect and GC/MS Analysis of Rosmarinus officinalis L. Essential Oil from Its Aerial Parts,” Planta Medica, Vol. 75, No. 5, 2009, pp. 508-511. doi:10.1055/s-0029-1185319
|
|
[55]
|
C. Liapi, G. Anifandis, I. Chinou, A. Kourounakis, S. Theodosopoulos and P. Galanopoulou, “Antinociceptive Properties of 1,8-Cineole and Beta-Pinene, from the Essential Oil of Eucalyptus camaldulensis Leaves, in Rodents,” Planta Medica, Vol. 73, 2007, pp. 1247-1254.
doi:10.1055/s-2007-990224
|
|
[56]
|
K. Hold, N. Sirisoma, T. Ikeda, T. Narahashi and J. Casida, “Alpha-Thujone (the Active Component of Absinthe): Gamma-Aminobutyric Acid Type A Receptor Modulation and Metabolic Detoxification,” Proceedings of the National Academy of Science USA, Vol. 97, No. 8, 2000, pp. 4417-4418. doi:10.1073/pnas.070042397
|
|
[57]
|
J. Vriens, G. Appendino and B. Nilius, “Pharmacology of Vanilloid Transient Receptor Potential Cation Channels,” Molecular Pharmacology, Vol. 75, No. 6, 2009, pp. 1262-1279. doi:10.1124/mol.109.055624
|
|
[58]
|
A. Vogt-Eisele, K. Weber, M. Sherkheli, G. Vielhaber, J. Panten, G. Gisselmann and H. Hatt, “Monoterpenoid Agonists of TRPV3,” British Journal of Pharmacology, Vol. 151, No. 4, 2007, pp. 530-540.
doi:10.1038/sj.bjp.0707245
|
|
[59]
|
S. Murakami, M. Matsuura, T. Satou, S. Hayashi and K. Koike, “Effects of the Essential Oil from Leaves of Alpinia zerumbet on Behavioral Alterations in Mice,” Natural Product Communications, Vol. 4, No. 1, 2009, pp. 129-132.
|
|
[60]
|
T. Umezu, K. Nagano, H. Ito, K. Kosakai, M. Sakaniwa and M. Morita, “Anticonflict Effects of Lavender Oil and Identification of Its Active Constituents,” Pharmacology Biochemistry and Behavior, Vol. 85, No. 4, 2006, pp. 713-721. doi:10.1016/j.pbb.2006.10.026
|
|
[61]
|
D. Lachenmeier and M. Uebelacker, “Risk Assessment of Thujone in Foods and Medicines Containing Sage and Wormword—Evidence for a Need of Regulatory Changes?” Regulatory Toxicology and Pharmacology, Vol. 58, No. 3, 2010, pp. 437-443. doi:10.1016/j.yrtph.2010.08.012
|
|
[62]
|
F. Napolitano, A. Bonito-Oliva, M. Federici, M. Carta, F. Errico, S. Magara, G. Martella, R. Nistico, D. Centonze, A. Pisani, H. Gu, N. Mercuri and A. Usiello, “Role of Aberrant Striatal Dopamine D1 Receptor/cAMP/Protein Kinase A/DARP32 Signaling in the Paradoxical Calming Effect of Amphetamine,” Journal of Neuroscience, Vol. 30, No. 33, 2010, pp. 11043-11056.
doi:10.1523/JNEUROSCI.1682-10.2010
|
|
[63]
|
H. Won, W. Mah, E. Kim, J. Kim, E. Hahm, M. Kim, S. Cho, J. Kim, H. Jang, S. Cho, B. Kim, M. Shin, J. Seo, J. Jeong, S. Choi, D. Kim, C. Kang and E. Kim, “GIT1 Is Associated with ADHD in Humans and ADHD-Like Behaviors in Mice,” Nature Medicine, Vol. 17, No. 5, 2011, pp. 566-572. doi:10.1038/nm.2330
|
|
[64]
|
R. Gong, C. Ding, J. Hu, Y. Lu, F. Liu, E. Mann, F. Xu, M. Cohen and M. Luo, “Role for the Membrane Receptor Guanylyl Cyclase-C in Attention Deficiency and Hyperactive Behavior,” Science, Vol. 333, No. 6049, 2011, pp. 1642-1646. doi:10.1126/science.1207675
|
|
[65]
|
T. Pringsheim T and T. Steeves, “Pharmacological Treatment for Attention Deficit Hyperactivity Disorder (ADHD) in Children with Comorbid Tic Disorders,” Cochrane Data-Base of Systemic Reviews, Vol. 13, No. 4, 2011.
|
|
[66]
|
D. Archer, C. Dupont, G. Constantine, J. Pickar and S. Olivier, “Desvenlafaxine for the Treatment of Vasomotor Symptoms Associated with Menopause: A Double Blind, Randomized, Placebo Controlled Trial of Efficacy and Safety,” American Journal of Obstetrics and Gynecology, Vol. 200, No. 3, 2009, pp. 238-248.
|
|
[67]
|
D. Deecher, C. Beyer and G. Johnston, “Desvenlafaxine Succinate: A New Serotonin and Norepinephrine Reuptake Inhibitor,” Journal of Pharmacology and Experimental Therapeutics, Vol. 318, No. 2, 2006, pp. 657-665.
doi:10.1124/jpet.106.103382
|
|
[68]
|
A. Subramanian and the Editorial Board, “Drug Facts and Comparisons,” Wolters Kluwer Health, St Louis, 2009.
|
|
[69]
|
D. Butt, M. Lock, J. Lewis, S. Ross and R. Moineddin, “Gabapentin for the Treatment of Menopausal Hot Flashes: A Randomized Controlled Trial,” Menopause, Vol. 15, 2008, pp. 310-318.
doi:10.1097/gme.0b013e3180dca175
|
|
[70]
|
D. Parker, J. Ong, V. Marino and D. Kerr, “Gabapentin Activates Presynaptic GABAB Heteroreceptors in Rat Cortical Slices,” European Journal of Pharmacology, Vol. 495, No. 2-3, 2004, pp. 137-143.
doi:10.1016/j.ejphar.2004.05.029
|
|
[71]
|
K. Mahmud, “Natural Hormone Therapy for Menopause,” Gynecology and Endocrinology, Vol. 26, No. 2, 2010, pp. 81-85. doi:10.3109/09513590903184134
|
|
[72]
|
P. Bernstein and G. Pohost, “Progesterone, Progestins and the Heart,” Reviews in Cardiovascular Medicine, Vol. 11, No. 3, 2010, pp. e141-149.
|
|
[73]
|
A. Howell and G. Evans, “Hormone Replacement Therapy and Breast Cancer,” Recent Results in Cancer Research, Vol. 88, 2011, pp.115-124.
|
|
[74]
|
E. Hogervorst, K. Yaffe, M. Richards and F. Huppert, “Hormone Replacement Therapy to Maintain Cognitive Function in Women with Dementia,” Cochrane Database Systematic Review, Vol. 1, 2010.
|
|
[75]
|
M. Craig, P. Maki and D. Murphy, “The Women’s Health Initiative Memory Study: Findings and Implications for Treatment,” Lancet Neurology, Vol. 4, No. 3, 2005, pp. 190-194.
|